Physician profile
Amber Peace
NPI 1902162167
$9,220.70
in general payments reported to CMS, 2019-2025
9 companies · $65.58 in 2025
The $65.58 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.25 · 2022: $46.13 · 2024: $9,089 · 2025: $65.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $487 · Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $486.82 |
| Food and Beverage | $167.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,054.97 | 2024 | |
| Amgen INC. | $34.23 | 2020-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.42 | 2025 | Caplyta |
| Vertex Pharmaceuticals Incorporated | $21.44 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.72 | 2025 | Exparel |
| Polynovo North America LLC | $17.82 | 2024 | Novosorb Btm |
| Bioventus LLC | $15.95 | 2024 | Exogen Ultrasound Bone Healing System |
| Alexion Pharmaceuticals, INC. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Peace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.